Full Text View
Tabular View
No Study Results Posted
Related Studies
Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma
This study has been completed.
Study NCT00988312   Information provided by University Hospital Carl Gustav Carus

First Received on October 1, 2009.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Multiple Myeloma
Plasmocytoma
Additional conditions recognized in this trial
Neoplasms, Plasma Cell
Plasmacytoma
More general conditions related to this trial
Blood Protein Disorders
Cardiovascular Diseases
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Paraproteinemias
Vascular Diseases
Additional drug interventions recognized in this trial
Immunoglobulin Idiotypes
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
University Hospital Carl Gustav Carus


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services